Globus Medical Inc. (GMED) intrinsic value & 10-year financials
Globus Medical Inc. (GMED) has a Graham intrinsic value of $130.21 per share. At $76.71 on Oct 17, 2026, the stock trades 41% below that value. Over the last 10 fiscal years revenue grew 20.1% a year to $2.9B, with an average return on invested capital of 9.3%.
- Graham intrinsic value
- $130.21
- Share price (Oct 17, 2026)
- $76.71
- Price vs Graham value
- 41% below
- Market cap
- $10.5B
- Revenue (FY2025)
- $2.9B
- Revenue growth (10-yr CAGR)
- 20.1%
- ROIC (10-yr avg)
- 9.3%
- Free cash flow (FY2025)
- $588.8M
GMED 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $2.9B | $537.9M | $3.92 | $588.8M | 16.3% | 11.2% |
| FY2024 | $2.5B | $103.0M | $0.75 | $405.2M | 6.6% | 3.8% |
| FY2023 | $1.6B | $122.9M | $1.07 | $165.2M | 8.5% | 3.5% |
| FY2022 | $1.0B | $190.2M | $1.85 | $104.4M | 22.3% | 10.0% |
| FY2021 | $958.1M | $149.2M | $1.44 | $219.4M | 17.9% | 9.0% |
| FY2020 | $789.0M | $102.3M | $1.01 | $135.1M | 14.1% | 6.8% |
| FY2019 | $785.4M | $155.2M | $1.52 | $101.2M | 21.9% | 11.6% |
| FY2018 | $713.0M | $156.5M | $1.54 | $121.9M | 23.7% | 13.0% |
| FY2017 | $636.0M | $107.3M | $1.10 | $108.2M | 25.4% | 11.4% |
| FY2016 | $564.0M | $104.3M | $1.08 | $131.0M | 27.3% | 12.3% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
GLOBUS MEDICAL INC is a consistent compounder, expanding top-line revenue at 20.1% annually over the past decade.
GLOBUS MEDICAL INC returns on capital have been average, hovering around 9.3% ROIC over the decade.
GLOBUS MEDICAL INC has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, GLOBUS MEDICAL INC is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $130.21 per share.